Also trades as: HCG.NS (NSE) · $vol 1M

₹666.00 ($6.91)

+0.05 (+0.01%)

BSE · Healthcare · Medical - Care Facilities · Tech Score Neutral · Power 39 · ₹100.6B mcap · 33M float · 0.166% daily turnover

Revenue

$25.4B +14.2% ▲

5Y CAGR: +20.2%

Gross Profit

$13.0B +8.9% ▲

5Y CAGR: +19.7%

Operating Income

$2.2B -80.0% ▼

5Y CAGR: -15.3%

Net Income

$138M -69.0% ▼

EPS (Diluted)

$0.96 -69.4% ▼

EBITDA

$4.5B +43.1% ▲

5Y CAGR: +46.8%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$14.0B	$16.9B	$19.1B	$22.2B	$25.4B
YoY Growth	+37.9%	+21.2%	+12.8%	+16.3%	+14.2%
Cost of Revenue	$6.5B	$7.7B	$8.6B	$10.3B	$12.4B
Gross Profit	$7.5B	$9.2B	$10.5B	$11.9B	$13.0B
Gross Margin	53.8%	54.3%	54.8%	53.6%	51.1%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$274M	$765M	$624M	$829M	$26M
Operating Expenses	$274M	$765M	$624M	$829M	$10.8B
Operating Income	$7.2B	$8.4B	$9.9B	$11.1B	$2.2B
Operating Margin	51.8%	49.8%	51.5%	49.8%	8.7%
Interest Expense	$936M	$975M	$995M	$1.5B	$1.8B
Income Before Tax	$878M	$449M	$677M	$570M	$269M
Tax Expense	$488M	$272M	$264M	$81M	$41M
Net Income	$537M	$293M	$482M	$444M	$138M
Net Margin	3.8%	1.7%	2.5%	2.0%	0.5%
EPS (Diluted)	$3.97	$2.10	$3.43	$3.14	$0.96
EBITDA	$1.8B	$2.4B	$2.7B	$3.1B	$4.5B
Shares Outstanding	135M	140M	140M	141M	143M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$5.3B	$5.5B	$5.6B	$5.9B	$6.1B	$6.5B	$6.3B	$6.5B
Cost of Revenue	$3.3B	$3.5B	$3.6B	$78M	$3.9B	$4.7B	$4.7B	$3.2B
Gross Profit	$2.0B	$2.1B	$2.0B	$5.9B	$2.2B	$1.7B	$1.6B	$3.3B
Gross Margin	37.1%	37.2%	35.2%	101.3%	36.0%	27.0%	25.5%	51.2%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$0	$0	$0	$829M	$16M	$0	$1.1B	$0
Operating Expenses	$0	$0	$0	$829M	$0	$2.7B	$1.1B	$2.7B
Operating Income	$2.0B	$2.1B	$2.0B	$4.9B	$2.2B	$588M	$471M	$623M
Operating Margin	37.1%	37.2%	35.2%	84.5%	36.0%	9.1%	7.5%	9.6%
Interest Expense	$337M	$360M	$407M	$442M	$455M	$436M	$448M	$427M
Income Before Tax	$190M	$276M	-$33M	$136M	$119M	$198M	-$61M	$12M
Tax Expense	$54M	$70M	-$110M	$68M	$59M	-$8M	$18M	-$28M
Net Income	$121M	$180M	$70M	$74M	$48M	$163M	-$94M	$22M
Net Margin	2.3%	3.2%	1.2%	1.3%	0.8%	2.5%	-1.5%	0.3%
EPS (Diluted)	$0.86	$1.28	$0.49	$0.52	$0.34	$1.16	$-0.67	$0.15
EBITDA	$875M	$1.0B	$598M	$834M	$1.0B	$1.3B	$994M	$1.1B
Shares Outstanding	140M	141M	142M	141M	140M	140M	141M	145M

HCG.BO BSE